US Incyte Corporation 2013 Misuse (Q9710)
From Open Risk Data
A data breach risk event
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
US Incyte Corporation 2013 Misuse
|
A data breach risk event
|
Statements
4D9563C2-D148-43B0-B769-E7458AC80BDF
January 2013
0 references
A biopharmaceutical company claims in court that a startup stole trade secrets by luring away a top scientist to bet the company on a new cancer drug - and then sell itself for $1.25 billion. Incyte Corporation sued Flexus Biosciences, its CEO Terry Rosen and its president and research director Juan Jaen, on Sept. 4 in New Castle County Court. Incyte claims the defendants hired away Jordan Fridman, its chief scientific officer, because he was one of only a few Incyte employees privy to the successful clinical results of the cancer drug known as IDO-1 inhibitor. Fridman is not a party to the complaint. Fridman, Rosen and Jaen are all referred to as Drs. in the complaint, though it is unclear whether they are M.D.s or Ph.D.s. Incyte claims Fridman had signed a confidentiality agreement with (English)
